Real-time enrollment status for this clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:52 AM UTC
| NCT Number | NCT06356272 |
| Recruiting Status | Recruiting |
| Condition | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
| Phase | Clinical Trial |
| Target Enrollment | 560 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of July 13, 2026: Clinical trial NCT06356272 is currently recruiting participants. This clinical trial study for clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06356272 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06356272 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.